PSIM_PSICY
ID PSIM_PSICY Reviewed; 309 AA.
AC A0A286LEZ7;
DT 05-DEC-2018, integrated into UniProtKB/Swiss-Prot.
DT 22-NOV-2017, sequence version 1.
DT 03-AUG-2022, entry version 10.
DE RecName: Full=Psilocybin synthase {ECO:0000305};
DE EC=2.1.1.345 {ECO:0000250|UniProtKB:P0DPA9};
DE AltName: Full=Psilocybin biosynthesis methyltransferase {ECO:0000303|PubMed:28763571};
GN Name=psiM {ECO:0000303|PubMed:28763571};
OS Psilocybe cyanescens.
OC Eukaryota; Fungi; Dikarya; Basidiomycota; Agaricomycotina; Agaricomycetes;
OC Agaricomycetidae; Agaricales; Strophariaceae; Psilocybe.
OX NCBI_TaxID=93625;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION, FUNCTION, AND PATHWAY.
RC STRAIN=FSU 12416;
RX PubMed=28763571; DOI=10.1002/anie.201705489;
RA Fricke J., Blei F., Hoffmeister D.;
RT "Enzymatic synthesis of psilocybin.";
RL Angew. Chem. Int. Ed. 56:12352-12355(2017).
RN [2]
RP FUNCTION.
RX PubMed=30283667; DOI=10.1002/evl3.42;
RA Reynolds H.T., Vijayakumar V., Gluck-Thaler E., Korotkin H.B.,
RA Matheny P.B., Slot J.C.;
RT "Horizontal gene cluster transfer increased hallucinogenic mushroom
RT diversity.";
RL Evol. Lett. 2:88-101(2018).
CC -!- FUNCTION: Methyltransferase; part of the gene cluster that mediates the
CC biosynthesis of psilocybin, a psychotropic tryptamine-derived natural
CC product (PubMed:28763571, PubMed:30283667). The first step in the
CC pathway is the decarboxylation of L-tryptophan to tryptamine by the
CC decarboxylase psiD. PsiD does not decarboxylate phenylalanine,
CC tyrosine, or 5-hydroxy- L -tryptophan (5-HTP) (PubMed:30283667). 4-
CC hydroxy-L-tryptophan is accepted as substrate by psiD as well. The
CC cytochrome P450 monooxygenase psiH then converts tryptamine to 4-
CC hydroxytryptamine. The kinase psiK catalyzes the 4-O-phosphorylation
CC step by converting 4-hydroxytryptamine into norbaeocystin. The
CC methyltransferase psiM then catalyzes iterative methyl transfer to the
CC amino group of norbaeocystin to yield psilocybin via a monomethylated
CC intermediate, baeocystin. PsiK kinase can also turn psilocin into
CC psilocybin. This activity may represent a protective mechanism to
CC rephosphorylate the unstable psilocin to the stable psilocybin in case
CC of intracellular ester cleavage (By similarity).
CC {ECO:0000250|UniProtKB:P0DPA9, ECO:0000269|PubMed:28763571,
CC ECO:0000269|PubMed:30283667}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=4-hydoxytryptamine 4-phosphate + 2 S-adenosyl-L-methionine = 2
CC H(+) + psilocybin + 2 S-adenosyl-L-homocysteine;
CC Xref=Rhea:RHEA:55568, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856,
CC ChEBI:CHEBI:59789, ChEBI:CHEBI:139070, ChEBI:CHEBI:139072;
CC EC=2.1.1.345; Evidence={ECO:0000250|UniProtKB:P0DPA9};
CC -!- COFACTOR:
CC Name=S-adenosyl-L-methionine; Xref=ChEBI:CHEBI:59789;
CC Evidence={ECO:0000305};
CC -!- PATHWAY: Secondary metabolite biosynthesis.
CC {ECO:0000305|PubMed:28763571}.
CC -!- SIMILARITY: Belongs to the methyltransferase superfamily. METTL16/RlmF
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; KY984103; ASU62241.1; -; mRNA.
DR AlphaFoldDB; A0A286LEZ7; -.
DR SMR; A0A286LEZ7; -.
DR GO; GO:0140381; F:4-hydroxytryptamine 4-phosphate methyltransferase activity; IEA:UniProtKB-EC.
DR GO; GO:0008173; F:RNA methyltransferase activity; IEA:UniProt.
DR GO; GO:0140380; P:psilocybin biosynthetic process; ISS:GO_Central.
DR Gene3D; 3.40.50.150; -; 1.
DR InterPro; IPR017182; METTL16/PsiM.
DR InterPro; IPR010286; METTL16/RlmF.
DR InterPro; IPR029063; SAM-dependent_MTases_sf.
DR PANTHER; PTHR13393; PTHR13393; 1.
DR Pfam; PF05971; Methyltransf_10; 1.
DR PIRSF; PIRSF037350; Mtase_ZK1128_prd; 1.
DR SUPFAM; SSF53335; SSF53335; 1.
PE 2: Evidence at transcript level;
KW Methyltransferase; S-adenosyl-L-methionine; Transferase.
FT CHAIN 1..309
FT /note="Psilocybin synthase"
FT /id="PRO_0000445829"
FT BINDING 75
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:Q86W50"
FT BINDING 107
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:Q86W50"
FT BINDING 131
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:Q86W50"
FT BINDING 183
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:Q86W50"
SQ SEQUENCE 309 AA; 34312 MW; D366DDC0B2D0F8F7 CRC64;
MHIRNPYRDG VDYQALAEAF PALKPHVTVN SDNTTSIDFA VPEAQRLYTA ALLHRDFGLT
ITLPEDRLCP TVPNRLNYVL WVEDILKVTS DALGLPDNRQ VKGIDIGTGA SAIYPMLACS
RFKTWSMVAT EVDQKCIDTA RLNVIANNLQ ERLAIIATSV DGPILVPLLQ ANSDFEYDFT
MCNPPFYDGA SDMQTSDAAK GFGFGVNAPH TGTVLEMATE GGESAFVAQM VRESLNLQTR
CRWFTSNLGK LKSLYEIVGL LREHQISNYA INEYVQGATR RYAIAWSFID VRLPDHLSRP
SNPDLSSLF